Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Sep 23, 2019

Biochemical and Imaging Biomarkers in PSC

By Konstantinos N. Lazaridis, M.D., @klazaridis

biomarker test

Primary Sclerosing Cholangitis (PSC) is a slowly progressing liver disease that lacks an ideal biomarker, which could predict disease progression. A biomarker is a measurable indicator of the presence or severity of a disease state. For example, body temperature is a biomarker of fever.

In this presentation, Dr. John Eaton, an Assistant Professor of Medicine and transplant Hepatologist from Mayo Clinic, discusses in detail the importance, current biomarkers of, and ongoing approaches to develop novel biomarkers for PSC.

View the full presentation from Dr. Eaton.

Liked by stella25

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

Please login or register to send an invite.